Clostridial toxin derivatives and methods to treat pain
AssigneeAllergan, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
Methods for treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to a targeting moiety, wherein the targeting moiety is selected from the group consisting of transmission compounds which can be released from neurons upon the transmission of pain signals by the neurons, and compounds substantially similar to the transmission compounds.
Claims8
A method for treating bone tumor pain, the method comprising the step of administering to a subject a therapeutically effective amount of a botulinum toxin component, wherein the component comprises both a proteolytic domain and an H chain, but does not contain an HC with a presynaptic binding function, covalently coupled to substance P, thereby alleviating bone tumor pain.
A method for treating bone tumor pain, the method comprising the step of administering to a subject a therapeutically effective amount of a botulinum toxin type A proteolytic domain covalently attached to a botulinum toxin type A translocational domain that is covalently attached to substance P, thereby alleviating bone tumor pain.
A method for treating pain in a subject with Osteoid Osteoma or Osteoblastoma, the method comprising the step of administering to a subject a therapeutically effective amount of LHN covalently coupled to substance P wherein LHN is obtained from botulinum toxin serotype A, B, C1, D, E, F or G, thereby alleviating pain due to Osteoid Osteoma or Osteoblastoma.
Dependencies are inferred from the claim text.